Advanced filters
News
Researchers at University College London (UCL) have developed artificial ‘mini-muscles’ that could…
News
Eteplirsen is designed to treat an estimated 13% of the Duchenne population amenable to the…
News
The 11th UK Neuromuscular Translational Research Conference was held in Cambridge on 19-20 April…
News
We are delighted to announce that the Medicines & Healthcare Products Regulatory Agency (MHRA)…
News
Summit Therapeutics has announced it has completed dosing participants in its Phase II PhaseOut DMD…
News
Solid Biosciences has announced that the FDA has allowed the high-dose group to be included in the …
News
Pfizer has announced the first participant for its US-based gene therapy trial, was recently dosed…
News
Poor bone health is common in individuals with Duchenne muscular dystrophy. However, there is…
News
We would like to invite you to take part in a study about anxiety in Duchenne muscular dystrophy.…
Your story
Kevin has taken on a number of cycling challenges, including the 96 mile Big Belter and cycling…